A recent report indicated that inhibition of DDX3 by RK-33, an inhibitor of DDX3, caused G1 cell cycle arrest, induced apoptosis, and promoted tumor regression in lung cancer via disruption of the DDX3-β-catenin axis; however, the underlying mechanism of β-catenin activation by DDX3 was not mentioned20. Here, DDX3X is linked to lung cancer.